CAS 2064-15-5
:5-[3-(diméthylamino)-2-méthylpropyl]-10,11-dihydro-5H-dibenzo[b,f]azépine-2-ol
- 5H-Dibenz(b,f)azepin-2-ol, 5-(3-(dimethylamino)-2-methylpropyl)-10,11-dihydro-
- 5-[3-(Dimethylamino)-2-methylpropyl]-10,11-dihydro-5H-dibenzo[b,f]azepin-2-ol
5H-Dibenz[b,f]azepin-2-ol, 5-[3-(dimethylamino)-2-methylpropyl]-10,11-dihydro-
CAS :Formule :C20H26N2OCouleur et forme :SolidMasse moléculaire :310.43322-Hydroxy Trimipramine
CAS :Produit contrôléStability Light Sensitive
Applications A metabolite of Trimipramine.
References De Jongh, G.D., et al.: Drug Metab. Dispos., 2, 48 (1981), Suckow, R.F., et al.: J. Pharm. Sci., 73, 1745 (1984), Fraser, A.D., et al.: J. Anal. Toxicol., 11, 168 (1987),Formule :C20H26N2OCouleur et forme :NeatMasse moléculaire :310.432-Hydroxy trimipramine
CAS :Trimipramine is a drug used to treat depression. It is an alicyclic compound that has been shown to have antidepressant effects in humans and animal models. Trimipramine can be detected in human plasma using liquid chromatography, with the enantiomer being separated from the racemate by chiral stationary phase. Trimipramine has been shown to have an effect on clinical response and plasma concentrations of other drugs, such as trifluoroacetic acid, when administered concurrently. Trimipramine also has interactions with other drugs through its inhibition of cytochrome P450 enzymes.
Formule :C20H26N2ODegré de pureté :Min. 95 Area-%Couleur et forme :PowderMasse moléculaire :310.43 g/mol


